Sterling, MA, United States of America

Craig Wallace

USPTO Granted Patents = 4 

Average Co-Inventor Count = 13.0

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
4 patents (USPTO):

Title: Celebrating the Innovations of Inventor Craig Wallace

Introduction: Craig Wallace, based in Sterling, MA, is a notable inventor recognized for his contributions to biomedical science through his innovative patents. With a total of four patents, he has made significant strides in developing treatments for diseases related to IL-17, a key player in inflammatory responses in the body.

Latest Patents: Among his latest innovations, Craig has focused on IL-17 binding proteins. These proteins are detailed in his patents, which describe their utility in compositions and methods for treating, preventing, and diagnosing IL-17 related diseases. Additionally, these patents cover the detection of IL-17 in cells, tissues, samples, and various compositions, showcasing his commitment to advancing medical science.

Career Highlights: Craig Wallace's professional journey is marked by his significant role at AbbVie Inc., a leading biopharmaceutical company. His expertise has contributed to numerous research initiatives aimed at tackling complex health issues linked to immune responses.

Collaborations: Throughout his career, Craig has collaborated with accomplished coworkers such as Chung-Ming Hsieh and Margaret Hugunin. These partnerships reflect a collective effort in driving forward research and innovation within the field, underscoring the importance of teamwork in scientific advancements.

Conclusion: Craig Wallace exemplifies the spirit of innovation through his work and patents focused on IL-17 binding proteins. His contributions continue to shape the landscape of biomedical research, illustrating the impact of dedicated inventors in developing therapeutic solutions for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…